Description

Updated: This item splits Line 5 of the Quarterly Part 1 – Loss Experience and Part 2 – Direct Premiums Written into Line 5.1 – Commercial multiple peril (non-liability portion) and Line 5.2 – Commercial multiple peril (liability portion). This change was missed in 2020-33BWG, which was effective with the 2022 Quarterly statement.

Effective 1st Quarter 2023

References: 2022-03BWG

New: A new Health Blank Analysis of Operations by Lines of Business supplement will be added for Life/Fraternal filers to capture revenue and expenses in the same detail as reported on the Health Analysis of Operations by Lines of Business. The new schedule will be part of the Health Supplement due for Life/Fraternal filers on March 1.

Updated: This item modifies the Analysis of Operations by Lines of Business in the Health Blank to include all of the health lines of business included in the Life/Fraternal Analysis of Operations by Lines of Business – Accident and Health.

Effective Annual 2023

References: 2021-17BWG Modified

Updated: Line items will be adjusted to include the specific lines of business reported on the Life/Fraternal Analysis of Operations by Lines of Business detail pages for Life (individual and group, annuities (individual and group) and A&H for Line 33 – Net gain from operations after dividends to policyholders, refunds to members and federal income taxes and before realized capital gains or (losses) of those pages.

Effective Annual 2023

References: 2021-20BWG Modified

Updated: This item adds a new Property supplement due March 1st. The new supplement will capture premium and loss data for Annual Statement Lines 17.1, 17.2 & 17.3 of the Exhibit of Premiums and Losses (State Page) – Other Liability by more granular lines of business. Companies will be expected to report 2022 prior year values at this level in the 2023 supplement.

Effective Annual 2023

References: 2022-04BWG

Updated: This item will create a revised/new supplement for Life companies that combines the Health Analysis of Operations by Line of Business (New) and Health Care Receivable Supplement pages (Exhibits 3 and 3A). This supplement will be due to the NAIC by March 1.

Effective Annual 2023

References: 2022-12BWG

Updated: This item modifies Exhibit 1, Parts 1 and 2 and Exhibit 8, Parts 1 and 2 to include the line of business detail reported on the Analysis of Operations by Lines of Business page. Crosscheck references on the Summary of Operations, Analysis of Operations, 5-Year Historical and Schedule S will be updated as a result of this modification. The quarterly Exhibit 1 will be modified effective Q1 2024.

Effective Annual 2023

References: 2022-14BWG Modified

Updated: This item removes the 5% of premium filing exemption for Schedule H, Part 5 from the instructions, making the schedule a required filing for Life and Property filers that write Health business.

Effective Annual 2023

References: 2022-15BWG

New: This item removes Part 3 of the Supplemental Health Care Exhibit and the Health Care Exhibit Expense Allocation Report. These items have been identified as parts of the Annual Statement that are either duplicative or not regularly used by regulators.

Effective Annual 2023

References: 2022-16BWG

Updated: This item adds three new electronic-only columns related to “derivatives with excluded components” to Schedule DB, Parts A and B, Sections 1 and 2. In addition, the instructions will be updated to add a new code of “%” to the Code column of each Schedule. This item coincides with Ref #2021-20 adopted by the Statutory Accounting Principles (E) Working Group (SAPWG) to reflect changes to SSAP No. 86 – Derivatives as adopted on August 10, 2022. This adoption is effective January 1, 2023, although early adoption was permitted at year-end 2022.

Effective Annual 2023

References: 2022-17BWG Modified, AP&P Ref #2021-20, SSAP No. 86

Updated: This item provides instructional corrections on the handling of Exchange Traded Funds and/or SVO Identified Funds within the IMR and AVR. Terminology will be updated to replace the classification of Bond Mutual Funds, which is no longer used in statement reporting.

Effective Annual 2023

References: 2022-18BWG

Updated: Schedules will be modified to include the line of business detail reported on the Analysis of Operations by Lines of Business pages. Definitions for life and annuity products will be added to the lines of business definitions in the health appendix. This will change the state page to be 28 columns wide and will expand the schedule to 2 pages for each state in which an entity is licensed. A modified version of the schedules will be required for Annual 2023 and all modifications must be fully implemented in the 2024 Annual Statement.

Effective Annual 2023

References: 2022-19BWG Modified

Updated: This item modifies the instructions and blanks to change the order of the Vision and Dental lines of business to be consistent with all other statement types.

Effective Annual 2023

References: 2022-20BWG

New: This item adds a new exhibit to identify premiums that are reportable for Market Conduct Annual Statement (MCAS) purposes. The exhibit will have a March 1st due date. The MCAS Lines of Business are as follows: Disability Income, Health, Homeowners, Individual Annuity, Individual Life, Lender-Placed Home and Auto, Long-Term Care, Other Health, Private Flood, Private Passenger Auto, Short-Term Limited Duration Health Plans, Travel.

Effective Annual 2023

References: 2023-02BWG Modified

Updated: This item removes Life crosschecks for Columns 2, 6 and 10 of the Accident and Health Policy Experience Exhibit. The Life crosschecks do not work correctly because Columns 2, 6 and 10 on the exhibit are on a direct basis and Exhibit 6 is on a direct plus assumed basis.

Effective Annual 2023

References: 2023-03BWG

Updated: This item adds instructions for the appointed actuary and qualified actuary contacts to the Jurat “electronic only” section for Annual Statement reporting exclusively (no Quarterly Statement impact). The qualified actuary contact will only be required for Life/Fraternal companies and Health companies that are required to file the Life Supplement.

Effective Annual 2023

References: 2023-04BWG Modified

Updated: This item adds clarifying language for mutual insurance companies to Schedule Y, Part 3, indicating mutual insurance companies that are part of the holding company organization should be included on the schedule.

Effective Annual 2023

References: 2023-08BWG

Updated:This item updates the three primary issue periods on the Long-Term Care Experience Reporting Form 2. The issue periods are not supposed to change each year but were mistakenly updated on the 2021 and 2022 Annual Blanks and Instructions.

Effective Annual 2023

References: 2023-10BWG Modified